Justin Meiklem

img

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES

VANCOUVER, CANADA, and REHOVOT, ISRAEL, July 18 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) is pleased to announce that it has closed its non-brokered private placement of convertible notes (the “Notes”) previously announced on July 7, 2023. The Company has issued Notes in the aggregate principal amount of […]

BIOHARVEST SCIENCES INC. ANNOUNCES CLOSING OF PRIVATE PLACEMENT OF CONVERTIBLE NOTES Read More »

BioHarvest Sciences Chief Medical Officer to speak at Collision Conference in Toronto

Dr. Brian Cornblatt will give the keynote address on the “HealthConf” Stage at Collision Vancouver, British Columbia, and Rehovot, Israel– (June 27, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) has been invited to one of the largest and fastest-growing technology conferences in North America. Its Chief Medical Officer,

BioHarvest Sciences Chief Medical Officer to speak at Collision Conference in Toronto Read More »

BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27

Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – June 26, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) announces that it will be participating in the Jefferies Vitamins and Supplements Conference, June 27, in London, England. BioHarvest Sciences CEO Ilan Sobel will be attending this prestigious industry conference as

BioHarvest Participates at Major Jefferies Investment Conference Tuesday June 27 Read More »

img

BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA

Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – June 21, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) has unveiled a plan to enter new consumption categories where VINIA will be incorporated to create unique and highly differentiated products for the Food & Beverage and the Nutraceuticals markets. VINIA’s

BioHarvest Unveils New Consumption Categories for its Flagship Product VINIA Read More »

BIOHARVEST SCIENCES ADDS RENOWNED SCIENTIST TO SCIENTIFIC ADVISORY BOARD

VANCOUVER, CANADA, AND REHOVOT, ISRAEL, June 6, 2023 – BioHarvest Sciences (CSE: BHSC) (OTCQB:CNVCF) announces that it has added Dr. John Paul SanGiovanni , world renowned nutritionist and Harvard-trained scientist, to its Medical and Scientific Advisory board. Dr. San Giovanni will act as a liaison with the spheres of Academia, Industry, and Government, helping spread the

BIOHARVEST SCIENCES ADDS RENOWNED SCIENTIST TO SCIENTIFIC ADVISORY BOARD Read More »

Vinia

BIOHARVEST REPORTS Q1 2023 RESULTS DEMONSTRATING STRONG YEAR OVER YEAR GROWTH

Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – May 31, 2023) – BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE:8MV) (“BioHarvest” or “the Company”) announces that it has released Q1 2023 results. Revenue of its flagship VINIA® product reached USD 2.2M, representing 209% growth compared to the same quarter of last year. Net loss for

BIOHARVEST REPORTS Q1 2023 RESULTS DEMONSTRATING STRONG YEAR OVER YEAR GROWTH Read More »